Sinopharm Vaccine or BBIBP-CorV
The Sinopharm Vaccine or BBIBP-CorV has been developed by the Beijing Bio-Institute of Biological Products(BBIBP) in collaboration with the Sinopharm Vaccine or BBIBP-CorV. The vaccine was given authorization by China's National Medical Products Administration on 31st December 2020 while it has been given authorization for its emergency use against SARS-CoV-2 by the World Health Organization on 7th May 2021.
In fact, this is the first vaccine from China that has been authorized by the WHO. However, it has been approved by many countries, though European Medicines Agency is yet to give it the approval for its use.
Recommendations for the use of this vaccine in immunization have already been issued by the WHO Strategic Advisory Group of Experts(SAGE). As per the guidelines, the vaccine should be provided to people in the age group 18 years or above.
It is an inactivated virus Covid-19 vaccine. It uses a killed or inactivated virus which is made to enter the body by means of a vaccine. It is treated as a foreign antigen by the body’s immune system, which responds by the formation of antibodies, which in turn build up immunity.
The BBIBP vaccine should be administered as an intramuscular injection. As per the recommendation of SAGE, the vaccine should be scheduled for two doses, each of 0.5ml with a time interval of three to four weeks in between.
The efficacy of the vaccine is determined on the basis of clinical trials. The complete two doses of this vaccine, taken at an interval of 3 weeks, have 79% efficacy after 14 or more days from the second dose if we consider the case of symptomatic Covid-19 infection. The efficacy is 79% against hospitalization.
The efficacy results are still under trial for the severe cases of infection in people with certain conditions such as comorbidities, pregnancy, or age factor 60 years or above. Based on the results of the first phase as well as second phase clinical trials, it can be determined how effective the vaccine is.
In countries such as Indonesia and Turkey, the effectiveness is shown to be 91.25% and 65.3% respectively, which is based on the ongoing phase three clinical trial. The Effectiveness was 78% initially but has been changed to 50.4% in Brazil.
The benefits of the Sinopharm Vaccine or BBIBP-CorV can be described in a number of ways such as-
- It is safe and has been approved on the basis of clinical trials.
- It is effective against the infection of Covid-19.
- It helps in developing immunity.
- Complete doses of vaccines enable a person to live a normal life full of activities without any fear of infection.
- It is the safest way to get immunized against the disease.
- It reduces the risk of transmission of the Covid-19 viruses.
The main advantage of this vaccine is the storage at a standard temperature of 2 to 8 degrees celsius, unlike the vaccines Pfizer and Moderna that are recommended to be stored at temperatures -70C and -20C. Hence, the storage is somewhat easier as compared to other vaccines.
There are common side effects, the nature being mild to moderate related to the Sinopharm Vaccine or BBIBP-CorV that may occur within a couple of days after getting vaccinated and disappear on their own after some days. Those side effects include pain and inflammation along with the swelling at the site of injection.
This drug can be used in below-mentioned conditions
This drug can cause below-mentioned side effects
Fever With Chills
Nausea Or Vomiting
Acute Disseminated Encephalomyelitis (ADEM)
Are there any pregnancy warnings?
This vaccine is found to be safe to be used in pregnant women. Clinical studies are still under process and there could be any unforeseen effect on the fetus which is yet to be identified.
Are there any breast-feeding warnings?
This vaccine is still under clinical trial and for now its effect is unknown in nursing women.
Is It safe with alcohol?
It is advised to avoid alcohol consumption for a brief period of time before getting vaccinated, as it might affect people’s immune responses to the jab.
Is it safe to drive while on this medicine?
This vaccine is not found to affect people's consciousness. If you feel dizzy, then you must avoid driving.
Does this affect kidney function?
Vaccine is safe to be administered to the patient with kidney disease of any severity.
This vaccine has been demonstrated to cause or worsen chronic liver diseases.
Below is the list of medicines, which contains Sinopharm Vaccine or BBIBP-CorV as ingredient
Sinopharm Vaccine or BBIBP-CorV works by teaching the immune system to help it produce antibodies against SARS-CoV-2 coronavirus. After administration, it shortens the time to stimulate the immune system and work against the virus and recover from the disease.
Lybrate is a medium to provide our audience with the common information on medicines and does not guarantee its accuracy or exhaustiveness. Even if there is no mention of a warning for any drug or combination, it never means that we are claiming that the drug or combination is safe for consumption without any proper consultation with an expert.
Lybrate does not take responsibility for any aspect of medicines or treatments. If you have any doubts about your medication, we strongly recommend you to see a doctor immediately.